U.S. flag

An official website of the United States government

NM_001199107.2(TBC1D24):c.724C>T (p.Arg242Cys) AND Inborn genetic diseases

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 16, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002371919.9

Allele description [Variation Report for NM_001199107.2(TBC1D24):c.724C>T (p.Arg242Cys)]

NM_001199107.2(TBC1D24):c.724C>T (p.Arg242Cys)

Gene:
TBC1D24:TBC1 domain family member 24 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16p13.3
Genomic location:
Preferred name:
NM_001199107.2(TBC1D24):c.724C>T (p.Arg242Cys)
Other names:
p.R242C:CGC>TGC
HGVS:
  • NC_000016.10:g.2496872C>T
  • NG_028170.1:g.26727C>T
  • NM_001199107.1:c.[724C>T]
  • NM_001199107.2:c.724C>TMANE SELECT
  • NM_020705.3:c.724C>T
  • NP_001186036.1:p.Arg242Cys
  • NP_001186036.1:p.Arg242Cys
  • NP_065756.1:p.Arg242Cys
  • NC_000016.9:g.2546873C>T
  • NM_001199107.1:c.724C>T
  • NM_001199107.1:c.[724C>T]
  • NM_001199107.2:c.724C>T
  • NM_020705.2:c.724C>T
  • Q9ULP9:p.Arg242Cys
Protein change:
R242C; ARG242CYS
Links:
UniProtKB: Q9ULP9#VAR_070915; OMIM: 613577.0007; dbSNP: rs398122965
NCBI 1000 Genomes Browser:
rs398122965
Molecular consequence:
  • NM_001199107.2:c.724C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_020705.3:c.724C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002671963Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(Nov 16, 2018)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The genetic basis of DOORS syndrome: an exome-sequencing study.

Campeau PM, Kasperaviciute D, Lu JT, Burrage LC, Kim C, Hori M, Powell BR, Stewart F, Félix TM, van den Ende J, Wisniewska M, Kayserili H, Rump P, Nampoothiri S, Aftimos S, Mey A, Nair LD, Begleiter ML, De Bie I, Meenakshi G, Murray ML, Repetto GM, et al.

Lancet Neurol. 2014 Jan;13(1):44-58. doi: 10.1016/S1474-4422(13)70265-5. Epub 2013 Nov 29.

PubMed [citation]
PMID:
24291220
PMCID:
PMC3895324

TBC1D24 genotype-phenotype correlation: Epilepsies and other neurologic features.

Balestrini S, Milh M, Castiglioni C, Lüthy K, Finelli MJ, Verstreken P, Cardon A, Stražišar BG, Holder JL Jr, Lesca G, Mancardi MM, Poulat AL, Repetto GM, Banka S, Bilo L, Birkeland LE, Bosch F, Brockmann K, Cross JH, Doummar D, Félix TM, Giuliano F, et al.

Neurology. 2016 Jul 5;87(1):77-85. doi: 10.1212/WNL.0000000000002807. Epub 2016 Jun 8.

PubMed [citation]
PMID:
27281533
PMCID:
PMC4932231
See all PubMed Citations (3)

Details of each submission

From Ambry Genetics, SCV002671963.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

The p.R242C pathogenic mutation (also known as c.724C>T), located in coding exon 1 of the TBC1D24 gene, results from a C to T substitution at nucleotide position 724. The arginine at codon 242 is replaced by cysteine, an amino acid with highly dissimilar properties. This mutation was identified in the homozgous and compound heterozygous states in multiple individuals with DOORS syndrome (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures syndrome) (Campeau PM et al. Lancet Neurol, 2014 Jan;13:44-58). Two cell lines expressing this mutation demonstrated shorter neurite length compared to wild type (Balestrini S et al. Neurology, 2016 Jul;87:77-85; Finelli MJ et al. Hum. Mol. Genet., 2018 Oct; doi.org/10.1093/hmg/ddy370). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024